<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4185">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04424082</url>
  </required_header>
  <id_info>
    <org_study_id>Karolinska</org_study_id>
    <nct_id>NCT04424082</nct_id>
  </id_info>
  <brief_title>External Dead Space in Ventilated COVID-19 Patients</brief_title>
  <official_title>Influence of External Dead Space on Volumetric Capnography Derived Parameters in Mechanically Ventilated COVID-19 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stockholm County Council, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to investigate the efficacy of volumetric capnography to detect changes in&#xD;
      dead space, CO2 elimination and shape factor parameters before and after disconnection of&#xD;
      external dead space in ventilated COVID-19 patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Covid-19 patients under mechanical ventilation are currently managed with a lung protective&#xD;
      strategy derived from ARDSnet recommendations. In order to minimize the risk of spread of&#xD;
      coronavirus, filters and associated respiratory tubing are incorporated to the breathing&#xD;
      circuit, thus increasing apparatus dead space with subsequent increase in dead space&#xD;
      ventilation. Considering the already often compromised ability for these patients to&#xD;
      adequately clear carbon dioxide (VCO2), adding an external dead space can potentially have a&#xD;
      substantial impact on CO2 homeostasis. The study will use volumetric capnography (Vcap) to&#xD;
      investigate the influence of external dead space on VCO2 and calculated alveolar dead space.&#xD;
&#xD;
      Objective: 1) To investigate the efficacy of Vcap to detect changes in dead space, VCO2 and&#xD;
      shape factor parameters before and after disconnection of external dead space.&#xD;
&#xD;
      2) To register the external dead space impact on arterial carbon dioxide tension (PaCO2).&#xD;
&#xD;
      3) To calculate the alveolar dead space based on Vcap data and arterial blood gas analysis&#xD;
      results.&#xD;
&#xD;
      Design and setting: Prospective observational study in an intensive care center for Covid-19&#xD;
      patients in a university hospital.&#xD;
&#xD;
      Patients: Covid-19 positive patients of all age groups under mechanical ventilation.&#xD;
      Exclusion criteria is ongoing ECMO treatment&#xD;
&#xD;
      Measurements and results: Vcap and Tcap parameters will be registered during mechanical&#xD;
      ventilation and correlated to an arterial blood gas sample. Part of the apparatus dead space&#xD;
      will then be reduced via removal of the heat and moister exchange filter (HME) with added&#xD;
      tubing resulting in a reduction in volume of approximately 80 ml (i.e. the known volume of&#xD;
      the HME filter and associated tubing). After the apparatus dead space is removed, the Vcap&#xD;
      will be recorded for approximately 15 minutes and an arterial blood gas will be drawn at the&#xD;
      end of the period. The HME and associated tubing will then be reattached to the breathing&#xD;
      circuit and Vcap and Tcap parameters will be recorded for approximately 30 minutes and an&#xD;
      arterial blood gas will be drawn. Vcap data will be analyzed for dead space, slope of phase&#xD;
      III, VCO2 and associated shape factor parameters and compared with Tcap parameters. Changes&#xD;
      in Vcap parameters will be tested for statistical significance using one and two-way ANOVA&#xD;
      for repeated measures and Bland-Altman analysis will be used for comparison.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 9, 2020</start_date>
  <completion_date type="Anticipated">November 7, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 7, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in carbon dioxide elimination (VCO2) i.e. ml CO2 eliminated/minute</measure>
    <time_frame>60 minutes</time_frame>
    <description>VCO2 is expected to increase after removal of the external dead space</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in alveolar dead space (a Vcap derived parameter)</measure>
    <time_frame>60 minutes</time_frame>
    <description>Removing the external dead space is expected to decrease alveolar dead space (ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial carbon dioxide tension (PaCO2).</measure>
    <time_frame>60 minutes</time_frame>
    <description>Removal of external dead space is expected to decrease PaCO2 (kPa).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Coronavirus</condition>
  <condition>ARDS, Human</condition>
  <arm_group>
    <arm_group_label>dead space removal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>external dead space will be removed and Vcap parameters (VCO2, PaCO2 and alveolar dead space) recorded before and after.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Removal of dead space filter</intervention_name>
    <description>Dead space filters will be removed and Vcap parameters (VCO2 ml/min, PaCO2 kPa, alveolar dead space in ml) recorded before and after removal</description>
    <arm_group_label>dead space removal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Covid-19 positive patients of all age groups under mechanical ventilation&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion criteria is ongoing ECMO treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Björn Persson, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Karolinska University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacob Karlsson, MD PhD</last_name>
    <phone>+46851779245</phone>
    <email>jacob.karlsson.1@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Per-Arne Lönnqvist, Prof</last_name>
    <phone>+46851777000</phone>
    <email>per-arne.lonnqvist@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>171 76</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Karlsson, MD PhD</last_name>
      <phone>+46851779245</phone>
      <email>jacob.karlsson.1@ki.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 7, 2020</study_first_submitted>
  <study_first_submitted_qc>June 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>November 10, 2020</last_update_submitted>
  <last_update_submitted_qc>November 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Jacob Karlsson</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

